Middle East and Africa Corneal Transplant Market
The Middle East and Africa corneal transplant market is expected to reach USD 31.28 million by 2031 from USD 21.86 million in 2023, growing at a CAGR of 4.6% in the forecast period of 2024 to 2031.... もっと見る
日本語のページは自動翻訳を利用し作成しています。
SummaryThe Middle East and Africa corneal transplant market is expected to reach USD 31.28 million by 2031 from USD 21.86 million in 2023, growing at a CAGR of 4.6% in the forecast period of 2024 to 2031.Market Segmentation: Middle East and Africa Corneal Transplant Market, By Procedure Type (Endothelial Keratoplasty, Penetrating Keratoplasty, Anterior Lamellar Keratoplasty (ALK), Corneal Limbal Stem Cell Transplant, Artifical Cornea Transplant, and Others), Type (Human Cornea and Synthetic), Donor Type (Autograft and Allograft), Graft Type (Partial Thickness Grafts (Lamellar) and Full Thickness Grafts (Penetrating)), Surgery Type (Conventional Surgery, Laser-Assisted Surgery), Indication (Fuch's Endothelial Dystrophy, Infectious Keratitis, Bullous Keratopathy, Keratoconus, Regraft Procedures, Corneal Scarring, Corneal Ulcers, and Others), Gender (Female and Male), Age Group (Geriatric, Adult, and Pediatric), End User (Hospitals, Eye Clinics, Ambulatory Surgical Centers, Academic & Research Institutes, and Others), Countries (South Africa, Egypt, Saudi Arabia, U.A.E., Israel, and rest of Middle East and Africa) - Industry Trends and Forecast to 2031 Overview of Middle East and Africa Corneal Transplant Market Dynamics: Driver • Increasing prevalence of eye diseases Restrain • High cost associated with corneal transplant surgery Opportunity • Rise in healthcare infrastructure Market Players: The key market players operating in the Middle East and Africa corneal transplant market are listed below: • ZEISS Group (Carl Zeiss Meditec AG.) • Alcon • CorneaGen • Ziemer Ophthalmic Systems AG • RUMEX International Co. Table of Contents1 INTRODUCTION 341.1 OBJECTIVES OF THE STUDY 34 1.2 MARKET DEFINITION 34 1.3 OVERVIEW OF THE MIDDLE EAST AND AFRICA CORNEAL IMPLANTS MARKET 34 1.4 CURRENCY AND PRICING 36 1.5 LIMITATIONS 36 1.6 MARKETS COVERED 36 2 MARKET SEGMENTATION 39 2.1 MARKETS COVERED 39 2.2 GEOGRAPHICAL SCOPE 40 2.3 YEARS CONSIDERED FOR THE STUDY 41 2.4 DBMR TRIPOD DATA VALIDATION MODEL 42 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 45 2.6 MULTIVARIATE MODELLING 46 2.7 MARKET END USER COVERAGE GRID 47 2.8 DBMR MARKET POSITION GRID 48 2.9 VENDOR SHARE ANALYSIS 49 2.10 SECONDARY SOURCES 50 2.11 ASSUMPTIONS 50 3 EXECUTIVE SUMMARY 51 4 PREMIUM INSIGHTS 57 4.1 PESTLE ANALYSIS 58 4.2 PORTERS FIVE FORCES ANALYSIS 59 5 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: REGULATIONS 60 5.1 REGULATORY AUTHORITIES IN THE ASIA-PACIFIC REGION 60 5.2 NORTH AMERICA REGULATORY SCENARIO 64 5.3 EUROPE REGULATORY SCENARIO 69 5.4 MIDDLE EAST AND AFRICA REGULATORY SCENARIO 71 5.5 SOUTH AMERICA REGULATORY SCENARIO 74 6 CUSTOMIZATION 79 7 MARKET OVERVIEW 86 7.1 DRIVERS 88 7.1.1 INCREASING PREVALENCE OF EYE DISEASES 88 7.1.2 RISING GERIATRIC POPULATION 89 7.1.3 TECHNOLOGICAL ADVANCEMENTS IN CORNEAL IMPLANTS 90 7.1.4 RISE IN MINIMALLY INVASIVE SURGERY IN CORNEAL TRANSPLANT 91 7.2 RESTRAINTS 92 7.2.1 HIGH COST ASSOCIATED WITH CORNEAL TRANSPLANT SURGERY 92 7.2.2 SHORTAGE OF DONORS IN CORNEAL TRANSPLANT 93 7.3 OPPORTUNITIES 94 7.3.1 RISE IN HEALTHCARE INFRASTRUCTURE 94 7.3.2 INCREASE IN PUBLIC AWARENESS AND EDUCATION 94 7.3.3 PARTNERSHIPS AND COLLABORATIONS ASSOCIATED WITH CORNEAL TRANSPLANTS 95 7.4 CHALLENGES 97 7.4.1 SURGICAL AND POST-SURGICAL COMPLICATIONS 97 7.4.2 LIMITED AWARENESS AND TRAINING 97 8 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY TYPE 99 8.1 OVERVIEW 100 8.2 HUMAN CORNEA 103 8.3 SYNTHETIC 104 9 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE 105 9.1 OVERVIEW 106 9.2 ENDOTHELIAL KERATOPLASTY 109 9.2.1 DESCEMET'S MEMBRANE ENDOTHELIAL KERATOPLASTY (DMEK) 110 9.2.2 DESCEMET'S STRIPPING ENDOTHELIAL KERATOPLASTY(DSEK)/DESCEMET'S STRIPPING AUTOMATED ENDOTHELIAL KERATOPLASTY (DSAEK) 110 9.3 PENETRATING KERATOPLASTY 110 9.4 ANTERIOR LAMELLAR KERATOPLASTY (ALK) 111 9.4.1 DEEP ANTERIOR LAMELLAR KERATOPLASTY (DALK) 111 9.4.2 SUPERFICIAL ANTERIOR LAMELLAR KERATOPLASTY (SALK) 111 9.5 CORNEAL LIMBAL STEM CELL TRANSPLANT 112 9.6 ARTIFICIAL CORNEA TRANSPLANT 112 9.7 OTHERS 113 10 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY DONOR TYPE 114 10.1 OVERVIEW 115 10.2 ALLOGRAFT 118 10.3 AUTOGRAFT 119 11 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY INDICATION 120 11.1 OVERVIEW 121 11.2 FUCH'S ENDOTHELIAL DYSTROPHY 124 11.3 INFECTIOUS KERATITIS 125 11.4 BULLOUS KERATOPATHY 126 11.5 KERATOCONUS 126 11.6 REGRAFT PROCEDURES 127 11.7 CORNEAL SCARRING 127 11.8 CORNEAL ULCERS 128 11.9 OTHERS 128 12 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE 129 12.1 OVERVIEW 130 12.2 PARTIAL THICKNESS GRAFTS (LAMELLAR) 133 12.2.1 DEEP LAMELLAR GRAFTS 134 12.2.2 SUPERFICIAL LAMELLAR GRAFTS 134 12.3 FULL THICKNESS GRAFTS (PENETRATING) 134 13 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE 135 13.1 OVERVIEW 136 13.2 CONVENTIONAL SURGERY 139 13.3 LASER-ASSISTED SURGERY 140 14 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY GENDER 141 14.1 OVERVIEW 142 14.2 FEMALE 145 14.3 MALE 146 15 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY AGE GROUP 147 15.1 OVERVIEW 148 15.2 GERIATRIC 151 15.3 ADULT 152 15.4 PEDIATRIC 153 16 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY END USER 154 16.1 OVERVIEW 155 16.2 HOSPITALS 158 16.3 EYE CLINICS 159 16.4 AMBULATORY SURGICAL CENTERS 159 16.5 ACADEMIC & RESEARCH INSTITUTES 160 16.6 OTHERS 160 17 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY REGION 161 17.1 MIDDLE EAST AND AFRICA 164 17.1.1 SOUTH AFRICA 168 17.1.2 SAUDI ARABIA 172 17.1.3 U.A.E. 176 17.1.4 EGYPT 178 17.1.5 ISRAEL 181 17.1.6 REST OF MIDDLE EAST AND AFRICA 185 18 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: COMPANY LANDSCAPE 186 18.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA 19 SWOT ANALYSIS 187 20 COMPANY PROFILES 188 20.1 ZEISS GROUP (CARL ZEISS MEDITEC AG.) 188 20.1.1 COMPANY SNAPSHOT 188 20.1.2 REVENUE ANALYSIS 188 20.1.3 COMPANY SHARE ANALYSIS 189 20.1.4 PRODUCT PORTFOLIO 189 20.1.5 RECENT DEVELOPMENTS 190 20.2 ALCON 191 20.2.1 COMPANY SNAPSHOT 191 20.2.2 REVENUE ANALYSIS 192 20.2.3 COMPANY SHARE ANALYSIS 192 20.2.4 PRODUCT PORTFOLIO 193 20.2.5 RECENT DEVELOPMENT 193 20.3 CORNEAGEN 194 20.3.1 COMPANY SNAPSHOT 194 20.3.2 COMPANY SHARE ANALYSIS 194 20.3.3 PRODUCT PORTFOLIO 195 20.3.4 RECENT DEVELOPMENT 196 20.4 ZIEMER OPHTHALMIC SYSTEMS AG 197 20.4.1 COMPANY SNAPSHOT 197 20.4.2 COMPANY SHARE ANALYSIS 197 20.4.3 PRODUCT PORTFOLIO 198 20.4.4 RECENT DEVELOPMENT 198 20.5 RUMEX INTERNATIONAL CO. 199 20.5.1 COMPANY SNAPSHOT 199 20.5.2 COMPANY SHARE ANALYSIS 199 20.5.3 PRODUCT PORTFOLIO 200 20.5.4 RECENT DEVELOPMENT 201 20.6 AJL OPHTHALMIC S.A. 202 20.6.1 COMPANY SNAPSHOT 202 20.6.2 PRODUCT PORTFOLIO 202 20.6.3 RECENT DEVELOPMENT 202 20.7 CORNEAT VISION 203 20.7.1 COMPANY SNAPSHOT 203 20.7.2 PRODUCT PORTFOLIO 203 20.7.3 RECENT DEVELOPMENT 203 20.8 FLORIDA LIONS EYE BANK 204 20.8.1 COMPANY SNAPSHOT 204 20.8.2 PRODUCT PORTFOLIO 204 20.8.3 RECENT DEVELOPMENT 204 20.9 KERAMED, INC. 205 20.9.1 COMPANY SNAPSHOT 205 20.9.2 PRODUCT PORTFOLIO 205 20.9.3 RECENT DEVELOPMENT 205 20.10 MASSACHUSETTS EYE AND EAR 206 20.10.1 COMPANY SNAPSHOT 206 20.10.2 PRODUCT PORTFOLIO 206 20.10.3 RECENT DEVELOPMENT 207 20.11 OCL VISION 208 20.11.1 COMPANY SNAPSHOT 208 20.11.2 SERVICE PORTFOLIO 208 20.11.3 RECENT DEVELOPMENT 208 20.12 OVATION INTERNATIONAL 209 20.12.1 COMPANY SNAPSHOT 209 20.12.2 PRODUCT PORTFOLIO 209 20.12.3 RECENT DEVELOPMENT 209 20.13 SAN DIEGO EYE BANK 210 20.13.1 COMPANY SNAPSHOT 210 20.13.2 SERVICE PORTFOLIO 210 20.13.3 RECENT DEVELOPMENT 210 21 QUESTIONNAIRE 211 22 RELATED REPORTS 215
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医薬)の最新刊レポート
Data Bridge Market Research社の医薬分野での最新刊レポート
本レポートと同じKEY WORD(transplant)の最新刊レポート
よくあるご質問Data Bridge Market Research社はどのような調査会社ですか?データブリッジマーケットリサーチ(Data Bridge Market Research)は500名以上の多様な分野のアナリストが所属するインドの調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2025/01/20 10:26 157.08 円 162.01 円 194.17 円 |